Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Genentech Inc.
Current Parent CompanyRoche
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $2,200,000
Year: 2016
Date: June 6, 2016
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: Pharmaceutical companies Genentech Inc. and OSI Pharmaceuticals LLC agreed to pay a total of $4.4 million to resolve multistate litigation alleging they made misleading statements about the effectiveness of the drug Tarceva to treat non-small cell lung cancer and thus caused false claims to be submitted to state Medicaid programs. The announcement did not specify how much each company would pay. Here we assume the amount was divided evenly between them. This was part of a larger $67 million settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Switzerland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.